following links are specific to:
summary & history
List of FDA-Approved drugs
Drug forms to be completed
Examples of completed forms
Safety Data Sheet
this drug fact sheet
all drug fact sheets
Sign-up via the INAD Program Management System (IPMS)
Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits
Relevant literature, technical publications, etc.
Authorization & Categorical Exclusion Letters
supportive and pivotal data needed to establish the effectiveness
of calcein to mark fin rays, scales, otoliths, and other calcified
fish or selected mussel tissues, via immersion baths.
|Source of drug:
|1269 Lattimore Road
Ferndale, WA 98248 USA
Attention: Jason Montgomery
Toll Free: 800-283-5292 ext 4175
standing-bath treatment only
A: 125 - 250 milligrams calcein per liter
Option B: 2.5 - 5.0 grams calcein per liter (finfish only)
A: Treatment duration is 1 - 6 hours
Option B: Treatment duration is 1 - 7 minutes (Note: Treatment
may include a pre-treatment with a 1 - 5% salt solution for
may be applied as a single treatment, or repeated treatments.
||None for fish; they
may be released immediately following treatment for those treated at less than 2 grams and for Federally Threatened and Endangered species.
None for mussels; due to their treatment at an early life stage and the limited human consumption
must collect mark retention and mortality data. Investigator
should also report general fish behavior and any adverse effects
relating to treatment.
or restrictions on use:
is restricted to finfish having a body weight of 2 grams or less.
of mussels is restricted to the following species: Higgins eye, hickory nut, black sandshell, pocketbook, fat mucket, sheepnose and maple leaf.
Repeated treatments may be conducted to establish mutltiple marks. However, an interval of at least 2 days should be observed between treatment events.
of calcein marking solution is allowed. Although used calcein marking
solution may be stored on station in a secure, leak-proof
container, it must ultimately be disposed of according to
procedures detailed in a general Waste-stream profile (see
INAD Study Protocol for specific instructions).
Investigator must follow all instructions in the Study Protocol
for INAD 10-987 regarding drug acquisition and handling, fish
treatment and disposition, and data reporting requirements.
per facility per year
contact for other information:
Bonnie Johnson, FWS - AADAP
||Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.